LETTER: EFFECTIVE USE OF CONTINUOUS ARTERIOVENOUS HEMODIALYSIS IN A CRITICALLY ILL HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT WITH ACUTE KIDNEY FAILURE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PAVAN M.; RANGANATH R.; CHAUDHARI A.P.; SURATKAL L.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Kidney Diseases Year:2010 | Volume:4 | Issue:3 Page(s): 267-271

Download Full-Text

View:

307

Download:

140

Cites:

Information Journal Paper

Title

LETTER: EFFECTIVE USE OF CONTINUOUS ARTERIOVENOUS HEMODIALYSIS IN A CRITICALLY ILL HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT WITH ACUTE KIDNEY FAILURE

Author(s)

PAVAN M. | RANGANATH R. | CHAUDHARI A.P. | SURATKAL L. | Issue Writer Certificate

Keywords

Not Registered.

Abstract

To the editor, Continuous arteriovenous hemodialysis (CAVHD) is a highly effective modality for the replacement of kidney function in patients with acute kidney failure. In patients with acute kidney failure and compromised circulation, hemodialysis may lead to serious hypotension or cardiac arrhythmia.1 This fact may limit possible treatment; restriction of the patient’s fluid intake may be attempted, usually with a concomitant restriction of nutrition. With continuous hemofiltration, however, almost any quantity of fluid can easily be removed over a 24- hour period. We had a patient on CAVHD who showed a good control of uremia and hypervolemia and stable hemodynamics while on CAVHD.

Cites

No record.

References

No record.

Cite

APA: Copy

PAVAN, M., RANGANATH, R., CHAUDHARI, A.P., & SURATKAL, L.. (2010). LETTER: EFFECTIVE USE OF CONTINUOUS ARTERIOVENOUS HEMODIALYSIS IN A CRITICALLY ILL HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT WITH ACUTE KIDNEY FAILURE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 4(3), 267-271. SID. https://sid.ir/paper/309035/en

Vancouver: Copy

PAVAN M., RANGANATH R., CHAUDHARI A.P., SURATKAL L.. LETTER: EFFECTIVE USE OF CONTINUOUS ARTERIOVENOUS HEMODIALYSIS IN A CRITICALLY ILL HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT WITH ACUTE KIDNEY FAILURE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2010;4(3):267-271. Available from: https://sid.ir/paper/309035/en

IEEE: Copy

M. PAVAN, R. RANGANATH, A.P. CHAUDHARI, and L. SURATKAL, “LETTER: EFFECTIVE USE OF CONTINUOUS ARTERIOVENOUS HEMODIALYSIS IN A CRITICALLY ILL HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENT WITH ACUTE KIDNEY FAILURE,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 4, no. 3, pp. 267–271, 2010, [Online]. Available: https://sid.ir/paper/309035/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops